Speeded Anomia Treatment in Chronic Post-stroke Aphasia

NCT ID: NCT05512884

Last Updated: 2023-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-15

Study Completion Date

2023-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of the study is to investigate the effect of a novel, speeded anomia therapy (Conroy et al., 2018) in a large population of patients with chronic post-stroke aphasia. The treatment will be delivered via a web application (QuickWord).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main aim is to test the clinical efficacy of a novel, web based, rehabilitation approach to aphasic word-finding difficulties (QuickWord). In an initial development and case-series evaluation, Conroy et al (2018, Brain) found that training for both speed as well as accuracy of naming generated much better outcomes to picture naming accuracy and also augmented the carry-over to connected speech production.

This is a randomised, crossover, clinical trial of QuickWord in a group of aphasic patients in the chronic post-stroke period. The comparison will be standard care. The main outcome measures are clinically relevant improvement in naming to confrontation, and spontaneous use of the target vocabulary in a connected speech sample (detailed picture description). Secondary outcome includes measured use of the vocabulary in a story-telling, connected speech assessment (retelling of the Cinderella story).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Speeded anomia therapy

21h of anomia therapy

Group Type EXPERIMENTAL

Speeded anomia therapy

Intervention Type BEHAVIORAL

The speeded anomia therapy was introduced as RISP (Repeated, Increasingly Speeded Production) by Conroy et al. (2018). Participants are asked to name the picture presented to them before an auditory stimulus ('beep' sound) at the end of item presentation. In each session the allotted response time is gradually reduced. After an incorrect response, participants are asked to repeat the word three times.

Standard care

Participants' typical daily routine

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Speeded anomia therapy

The speeded anomia therapy was introduced as RISP (Repeated, Increasingly Speeded Production) by Conroy et al. (2018). Participants are asked to name the picture presented to them before an auditory stimulus ('beep' sound) at the end of item presentation. In each session the allotted response time is gradually reduced. After an incorrect response, participants are asked to repeat the word three times.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Native English speakers
* Age 18 years or above
* Stroke (any type) greater than 12 months post onset
* No history of neurological disorders / psychiatric disorders
* Normal or corrected-to-normal hearing \& vision
* Able to give informed consent
* Currently not receiving Speech \& Language therapy
* Minimal repetition skills (\>40% on an immediate word repetition test)
* Evidence of naming difficulties (\<90% in Boston Naming Test - Goodglass et al., 1983)

Exclusion Criteria

* Non-native English speakers
* Less than 18 years old
* Stroke less than 12 months post onset
* History of neurological disorders / psychiatric disorders
* Uncorrected hearing \& vision
* Unable to give informed consent
* Currently receiving Speech \& Language therapy
* Insufficient repetition skills (\<40% on an immediate word repetition test)
* Good naming performance (\>90% in Boston Naming Test - Goodglass et al., 1983)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cambridge University Hospitals NHS Foundation Trust

OTHER

Sponsor Role collaborator

University of Cambridge

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Matthew A. Lambon Ralph

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthew Lambon Ralph, DPhil

Role: PRINCIPAL_INVESTIGATOR

MRC Cognition and Brain Sciences Unit, University of Cambridge

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MRC Cognition & Brain Sciences Unit

Cambridge, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eleni Zevgolatakou, MSc

Role: CONTACT

+447724386296

Ajay Halai, PhD

Role: CONTACT

+447508764348

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eleni Zevgolatakou, MSc

Role: primary

07724386296

References

Explore related publications, articles, or registry entries linked to this study.

Conroy P, Sotiropoulou Drosopoulou C, Humphreys GF, Halai AD, Lambon Ralph MA. Time for a quick word? The striking benefits of training speed and accuracy of word retrieval in post-stroke aphasia. Brain. 2018 Jun 1;141(6):1815-1827. doi: 10.1093/brain/awy087.

Reference Type BACKGROUND
PMID: 29672757 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

01/8/094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tACS to Enhance Language Abilities
NCT06092814 RECRUITING NA
Stepped Care for Aphasia
NCT05851573 COMPLETED NA
Criterion-learning Based Naming Treatment in Aphasia
NCT06364709 ENROLLING_BY_INVITATION NA
Intention Treatment for Anomia
NCT04267198 COMPLETED NA